Fluidigm Co. (NASDAQ:FLDM) Insider Levin Easterly Partners Llc Sells 1,629 Shares

Fluidigm Co. (NASDAQ:FLDM) insider Levin Easterly Partners Llc sold 1,629 shares of the firm’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $12.25, for a total transaction of $19,955.25. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Levin Easterly Partners Llc also recently made the following trade(s):

  • On Monday, July 29th, Levin Easterly Partners Llc sold 82,585 shares of Fluidigm stock. The stock was sold at an average price of $11.97, for a total transaction of $988,542.45.
  • On Friday, July 26th, Levin Easterly Partners Llc sold 195,982 shares of Fluidigm stock. The stock was sold at an average price of $11.92, for a total transaction of $2,336,105.44.
  • On Wednesday, July 24th, Levin Easterly Partners Llc sold 28,090 shares of Fluidigm stock. The stock was sold at an average price of $11.78, for a total transaction of $330,900.20.
  • On Monday, July 22nd, Levin Easterly Partners Llc sold 61,432 shares of Fluidigm stock. The stock was sold at an average price of $11.57, for a total transaction of $710,768.24.
  • On Friday, July 19th, Levin Easterly Partners Llc sold 83,728 shares of Fluidigm stock. The stock was sold at an average price of $11.50, for a total transaction of $962,872.00.
  • On Wednesday, July 17th, Levin Easterly Partners Llc sold 134,487 shares of Fluidigm stock. The stock was sold at an average price of $11.32, for a total transaction of $1,522,392.84.
  • On Friday, June 28th, Levin Easterly Partners Llc sold 157,349 shares of Fluidigm stock. The stock was sold at an average price of $12.30, for a total transaction of $1,935,392.70.
  • On Monday, July 1st, Levin Easterly Partners Llc sold 186,759 shares of Fluidigm stock. The stock was sold at an average price of $12.31, for a total transaction of $2,299,003.29.
  • On Tuesday, June 25th, Levin Easterly Partners Llc sold 217,148 shares of Fluidigm stock. The stock was sold at an average price of $12.28, for a total transaction of $2,666,577.44.

Fluidigm stock traded down $1.16 during mid-day trading on Monday, reaching $6.89. The company’s stock had a trading volume of 2,152,439 shares, compared to its average volume of 885,741. The stock has a market cap of $555.61 million, a P/E ratio of -8.61 and a beta of 2.15. Fluidigm Co. has a 12 month low of $6.55 and a 12 month high of $14.90. The firm’s 50 day simple moving average is $11.72. The company has a debt-to-equity ratio of 0.30, a current ratio of 3.26 and a quick ratio of 2.86.

Fluidigm (NASDAQ:FLDM) last released its earnings results on Thursday, August 1st. The medical research company reported ($0.20) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.08). The business had revenue of $28.20 million during the quarter, compared to the consensus estimate of $30.16 million. Fluidigm had a negative net margin of 60.45% and a negative return on equity of 43.75%. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. As a group, analysts predict that Fluidigm Co. will post -0.5 earnings per share for the current fiscal year.

A number of institutional investors have recently added to or reduced their stakes in the stock. Zurcher Kantonalbank Zurich Cantonalbank bought a new position in shares of Fluidigm in the 2nd quarter valued at about $68,000. BNP Paribas Arbitrage SA grew its position in shares of Fluidigm by 3,543.1% in the 1st quarter. BNP Paribas Arbitrage SA now owns 6,849 shares of the medical research company’s stock valued at $91,000 after acquiring an additional 6,661 shares during the period. Aperio Group LLC bought a new position in shares of Fluidigm in the 2nd quarter valued at about $124,000. Metropolitan Life Insurance Co NY bought a new position in shares of Fluidigm in the 1st quarter valued at about $151,000. Finally, United Services Automobile Association bought a new position in shares of Fluidigm in the 4th quarter valued at about $102,000. 93.25% of the stock is owned by institutional investors and hedge funds.

A number of equities research analysts recently commented on the stock. BidaskClub upgraded shares of Fluidigm from a “sell” rating to a “hold” rating in a report on Friday, July 19th. Piper Jaffray Companies raised their target price on shares of Fluidigm from $14.00 to $16.00 and gave the company an “overweight” rating in a research report on Friday, May 3rd. Zacks Investment Research raised shares of Fluidigm from a “hold” rating to a “buy” rating and set a $14.00 target price for the company in a research report on Wednesday, July 3rd. Finally, ValuEngine downgraded shares of Fluidigm from a “buy” rating to a “hold” rating in a research report on Wednesday, June 12th. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Fluidigm has a consensus rating of “Buy” and an average target price of $14.75.

About Fluidigm

Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research in the United States and Europe. It offers analytical systems comprising Helios, a CyTOF system, Hyperion imaging system, and Hyperion tissue imager; and assays and reagents, including Maxpar reagents and Maxpar human immune monitoring panel kit and workflow.

Featured Article: Bollinger Bands

Insider Buying and Selling by Quarter for Fluidigm (NASDAQ:FLDM)

Receive News & Ratings for Fluidigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm and related companies with MarketBeat.com's FREE daily email newsletter.